Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
07/2003
07/30/2003CN1116305C Peptide derivatives
07/30/2003CN1116304C Organic compound
07/30/2003CN1116288C Urea derivatives as inhibitors of inosine-5'-phospho-dehydrogenase
07/30/2003CN1116286C 4-anilinoquinazoline derivatives
07/30/2003CN1116270C Novel retinoids derivs.
07/30/2003CN1116065C Plaster for treating ostalgia and its preparing process
07/30/2003CN1115965C Natural plant disinfectant and its preparation
07/29/2003US6600059 Protecting cells from injury due to intrinsic membrane lysis, oxidation and/or invasion by destructive agents. Even more particularly, the present invention provides compositions and methods for treating or prophylactically inhibiting
07/29/2003US6600058 Vitamin D derivatives with carbo- or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments
07/29/2003US6600052 With a ring cyclizing reagent to form the compound of Formula V to yield a compound of Formula V: inhibitors of the cyclooxygenase- II enzyme. and antiinflammatory agents and analgesic pharmaceutical agents.
07/29/2003US6600038 Carbamoyl tetrahydropyridine derivatives
07/29/2003US6600037 4,5-disubstituted-2-aminopyrimidines
07/29/2003US6600030 Nucleotide sequences which code binding protein for use in diagnosis and treatment of asthma, arthritis, Crohn's and Grave's diseases and cystic fibrosis
07/29/2003US6599938 Optionally substituted Schiff base condensation products comprising an amino acid component and a benzaldehyde component, that have MIF (macrophage migration inhibitory factor) antagonist activity
07/29/2003US6599910 Substituted triazole compounds
07/29/2003US6599908 Fused polycyclic 2-aminopyrimidine derivatives
07/29/2003US6599906 Administering to dental pulp or a trigeminal nerve region of the mammal a first injection of a composition comprising a local anesthetic; and a compound that binds to an SS1 or SS2 subunit of a sodium channel, such as tetrodotoxin
07/29/2003US6599888 These combinations have shown a synergistic effect compared with compositions containing either glucosamine alone, or chondroitin sulfate alone
07/29/2003US6599727 Human poly (ADP-ribose) polymerase 2 materials and methods
07/29/2003US6599719 For therapy of rheumatoid arthritis, tumors
07/29/2003US6599706 Recombinant PR-3 and assays employing the same
07/29/2003US6599529 Modified release multiple-units compositions of non-steroid anti-inflammatory drug substances (NSAIDs)
07/29/2003US6599506 Inhibiting integrin-associated diseases; rejection of transplanted organs, allergies, and autoimmune diseases
07/29/2003US6599499 Uses of diterpenoid triepoxides as an anti-proliferative agent
07/29/2003CA2244621C 4-aminopyrrole (3,2-d) pyrimidines as neuropeptide y receptor antagonists
07/29/2003CA2185036C Use of a non photosynthetic filamentous bacteria extract and composition containing the same
07/29/2003CA2102530C Therapeutic agent
07/29/2003CA2054473C Novel 3-cycloalkyl-propanamides, their tautomers and salts, process for their preparation, application as medicines and compositions containing them
07/29/2003CA2050812C Pregna-1,4-diene-3,20-dione-16-17-acetal-21 esters, process for their preparation, compositions, and methods for the treatment of inflammatory conditions
07/29/2003CA2048959C 3-(1,2-benzisoxazol-3-yl)-4-pyridinamines and derivatives
07/24/2003WO2003060468A2 Macrophage migration inhibitory factor (mif) promoter polymorphism in inflammatory disease
07/24/2003WO2003060149A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
07/24/2003WO2003060126A1 Rheumatoid arthritis disease sensitive gene, its protein, method and kit of judging the onset of rheumatoid arthritis using the same, and method and drugs for treating rheumatoid arthritis
07/24/2003WO2003060090A2 Novel cytokine zcytor17 ligand
07/24/2003WO2003060085A2 Mammalian neural stem cells, compositions and uses thereof
07/24/2003WO2003060082A2 Use of modified pyrimidine compounds to promote stem cell migration and proliferation
07/24/2003WO2003060072A2 Recombinant polypeptides
07/24/2003WO2003060034A1 Anion generating material and skin treating agent using the same
07/24/2003WO2003059921A1 Mmp inhibitors
07/24/2003WO2003059899A1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof
07/24/2003WO2003059898A2 Eponemycin and epoxomicin analogs and uses thereof
07/24/2003WO2003059893A1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
07/24/2003WO2003059891A1 Substituted pyridazinones as inhibitors of p38
07/24/2003WO2003059884A1 Modulators of lxr
07/24/2003WO2003059880A1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these
07/24/2003WO2003059834A1 Glass-ceramic composite containing nanoparticles
07/24/2003WO2003059370A1 Crude drug compositions for treating or preventing arthritic diseases and the preparation process
07/24/2003WO2003059368A1 Active substances for use in cosmetic and/or pharmaceutical products, obtainable from the fermentation of plant components and/or plant extracts
07/24/2003WO2003059366A1 Skin perparation for external use containing purpuricenus temminckii frass as the active ingredient
07/24/2003WO2003059357A1 Pregnane steroids for use in the treatment of cns disorders
07/24/2003WO2003059353A1 Tyrosyl derivatives and their use as p2x7 receptor modulators
07/24/2003WO2003059348A1 2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as beta3 agonists
07/24/2003WO2003059347A1 Use of cox-2 inhibitors in combination with antiviral agents for the treatment of papilloma virus infections
07/24/2003WO2003059344A1 Suppositories containing indole derivative
07/24/2003WO2003059323A2 Stable salts of o-acetylsalicylic acid containing basic amino acids ii
07/24/2003WO2003059294A2 Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor
07/24/2003WO2003059288A2 Liposome drug delivery of polycyclic, aromatic, antioxidant or anti-inflammatory compounds
07/24/2003WO2003059282A2 Human monoclonal antibodies against cd30
07/24/2003WO2003059276A2 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof
07/24/2003WO2003059270A2 Method for reducing morbidity and mortality in critically ill patients
07/24/2003WO2003059269A2 Acridone inhibitors of impdh enzyme
07/24/2003WO2003059264A2 Methods for the induction of professional and cytokine-producing regulatory cells
07/24/2003WO2003059194A2 Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs
07/24/2003WO2003045999A3 Human vanilloid receptor protein and polynucleotide sequence encoding same
07/24/2003WO2003032918A3 Treatment of infectious disease using interleukin-1 beta converting enzyme (ice)/ced-3 family inhibitors
07/24/2003WO2003032910A3 Carbinols for the treatment of neuropathic dysfunction
07/24/2003WO2003018612A3 Extracellular messengers
07/24/2003WO2003011895A3 Compositions and methods for modulation of immune responses
07/24/2003WO2003009741A3 Methods for treating joint inflammation, pain, and loss of mobility
07/24/2003WO2003006645A3 Method and composition for inhibiting heparanase activity
07/24/2003WO2002100325A3 Polyvalent nanoparticles
07/24/2003WO2002060942A3 Protein modification and maintenance molecules
07/24/2003WO2002059323A3 Aminoacyl trna synthetases
07/24/2003US20030140358 Transgenic mammal coding serine protease inhibitor which is expressed in mammary gland tissue and products for treating immunosuppression disorders and angioedema
07/24/2003US20030139597 Novel Cyclic hydroxamic acid as metalloproteinase inhibitors
07/24/2003US20030139590 Comprises nucleotide sequences coding orphan receptor 25 for detecting modulators of platelet activating factor (PAF) activity; antiinflammatory agents; gene/translation inhibition; drug screening
07/24/2003US20030139585 Oligonucleotide derivatives which are at least partly double-stranded and which have a 2'5'-linked oligonucleotide residue on at least one 3' end; use in formulating pharmaceutical for tumor therapy, infectious diseases
07/24/2003US20030139462 Antiinflammatory agents; autoimmune disease; antiarthritic agents
07/24/2003US20030139453 Difluorobutyric acid metalloprotease inhibitors
07/24/2003US20030139452 Pyrazole-derived kinase inhibitors and uses thereof
07/24/2003US20030139446 Reacting with acid mixed with solvent; salt formation
07/24/2003US20030139439 Uses of diterpenoid triepoxides as an anti-proliferative agent
07/24/2003US20030139435 N-heterocyclic inhibitors of TNF-alpha expression
07/24/2003US20030139434 Combinations comprising dipeptidylpeptidase-iv inhibitor
07/24/2003US20030139425 Piperazine derivatives and their use as anti-inflammatory agents
07/24/2003US20030139417 Cyclopropane CGRP antagonists, medicaments containing these compounds, and method for the production thereof
07/24/2003US20030139415 Novel heterocycles 3
07/24/2003US20030139414 Heterocyclic side chain containing, n-substituted metalloprotease inhibitors
07/24/2003US20030139413 Novel 1,3-dihydro-2h-indol-2-one derivatives, preparation method and pharmaceutical composition containing them
07/24/2003US20030139410 Use of modified pyrimidine compounds to promote stem cell migration and proliferation
07/24/2003US20030139407 Efficient synthesis of 5-heteroatom-containing -pyrazoles
07/24/2003US20030139406 Antiinflammatory agents; antidepressants; respiratory system disorders; cognition activators
07/24/2003US20030139402 Antiinflammatory agents; Alzheimer's disease; cardiovascular disorders
07/24/2003US20030139400 Controlling cell differentiation; antiinflammatory agents
07/24/2003US20030139399 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
07/24/2003US20030139398 Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders
07/24/2003US20030139394 Dibenzodiazepine derivatives, their preparation and use
07/24/2003US20030139379 Autoimmune disease, osteoporosis, rheumatic diseases, skin disorders
07/24/2003US20030139376 Lipoxin A4 analogs
07/24/2003US20030139371 Drug for combating sexual dysfunctions
1 ... 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 ... 1272